| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.6 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |